Dr Sarah (Sally) Lord

Senior Research Fellow
Medicine, Sydney Medical School
NHMRC Clinical Trials Centre

T: +61 2 9562 5322
F: +61 2 9565 1863

On this page

Themes | Keywords | Publications



Cancer; Epidemiology; Evidence-based medicine; Biological markers


2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009


  • Lee, C., Lord, S., Grunewald, T., Gebski, V., Hardy-Bessard, A., Sehouli, J., Woie, K., Heywood, M., Schauer, C., Vergote, I., Scambia, G., Ferrero, A., Harter, P., Pujade-Lauraine, E., Friedlander, M. (2015), Impact of secondary cytoreductive surgery on survival in patients with platinum sensitive recurrent ovarian cancer: Analysis of the CALYPSO Trial. Gynecologic Oncology. 136(1), 18-24. [Abstract]


  • Than, M., Aldous, S., Lord, S., Goodacre, S., Frampton, C., Troughton, R., George, P., Florkowski, C., Ardagh, M., Smyth, D., Jardine, D., Peacock, W., Young, J., Hamilton, G., Deely, J., Cullen, L., Richards, A. (2014), A 2-Hour Diagnostic Protocol for Possible Cardiac Chest Pain in the Emergency Department: A Randomized Clinical Trial. JAMA Internal Medicine. 174(1), 51-58. [Abstract]
  • Barz, T., Staub, L., Melloh, M., Hamann, G., Lord, S., Chatfield, M., Bossuyt, P., Lange, J., Merk, H. (2014), Clinical validity of the nerve root sedimentation sign in patients with suspected lumbar spinal stenosis. Spine Journal. 14(4), 667-674. [Abstract]
  • Barz, T., Melloh, M., Lord, S., Kasch, R., Merk, H., Staub, L. (2014), A conceptual model of compensation/decompensation in lumbar segmental instability. Medical Hypotheses. 83(3), 312-316. [Abstract]
  • Tjokrowidjaja, A., Lee, C., Houssami, N., Lord, S. (2014), Metastatic breast cancer in young women: a population-based cohort study to describe risk and prognosis. Internal Medicine Journal. 44(8), 764-770. [Abstract]
  • Barz, T., Melloh, M., Staub, L., Lord, S., Lange, J., Merk, H. (2014), Increased intraoperative epidural pressure in lumbar spinal stenosis patients with a positive nerve root sedimentation sign. European Spine Journal. 23(5), 985-990. [Abstract]


  • Lee, C., Simes, R., Brown, C., Gebski, V., Pfisterer, J., Swart, A., Berton-Rigaud, D., Plante, M., Skeie-Jensen, T., Vergote, I., Schauer, C., Pisano, C., Parma, G., Baumann, K., Ledermann, J., Pujade-Lauraine, E., Bentley, J., Kristensen, G., Belau, A., Nankivell, M., Canzler, U., Lord, S., Kurzeder, C., Friedlander, M. (2013), A prognostic nomogram to predict overall survival in patients with platinum-sensitive recurrent ovarian cancer. Annals of Oncology. 24(4), 937-943. [Abstract]
  • Horvath, A., Lord, S., Stjohn, A., Sandberg, S., Cobbaert, C., Lorenz, S., Monaghan, P., Verhagen-Kamerbeek, W., Ebert, C., Bossuyt, P. (2013), From biomarkers to medical tests: the changing landscape of test evaluation. Clinica Chimica Acta. 27(427C), 49-57. [Abstract]
  • Fox, P., Hudson, M., Brown, C., Lord, S., Gebski, V., De Souza, P., Lee, C. (2013), Markers of systemic inflammation predict survival in patients with advanced renal cell cancer. British Journal of Cancer. 109(1), 147-153. [Abstract]
  • Melloh, M., Lord, S., Staub, L., Merk, H., Barz, T. (2013), Letters. Spine. , 968. [Abstract]
  • Campbell, L., Novak, I., McIntyre, S., Lord, S. (2013), A KT intervention including the evidence alert system to improve clinician's evidence-based practice behavior-a cluster randomized controlled trial. Implementation Science. 8(1), 132. [Abstract]
  • Martin, A., Lord, S., Verry, H., Stockler, M., Emery, J. (2013), Risk assessment to guide prostate cancer screening decisions: a cost-effectiveness analysis. The Medical Journal of Australia. 198(10), 546-550. [Abstract]


  • Lew, J., Howard, K., Gertig, D., Smith, M., Clements, M., Nickson, C., Shi, J., Dyer, S., Lord, S., Creighton, P., Kang, Y., Tan, J., Canfell, K. (2012), Expenditure and resource utilisation for cervical screening in Australia. BMC Health Services Research. 12(1), 446. [Abstract]
  • Lord, S., Marinovich, M., Patterson, J., Wilcken, N., Kiely, B., Gebski, V., Crossing, S., Roder, D., Gattellari, M., Houssami, N. (2012), Incidence of metastatic breast cancer in an Australian population-based cohort of women with non-metastatic breast cancer at diagnosis. Medical Journal of Australia. 196(11), 688-692. [Abstract]
  • Walter, S., Macaskill, P., Lord, S., Irwig, L. (2012), Effect of dependent errors in the assessment of diagnostic or screening test accuracy when the reference standard is imperfect. Statistics in Medicine. 31(11-12), 1129-1138. [Abstract]
  • Verry, H., Lord, S., Martin, A., Gill, G., Lee, C., Howard, K., Wetzig, N., Simes, J. (2012), Effectiveness and cost-effectiveness of sentinel lymph node biopsy compared with axillary node dissection in patients with early-stage breast cancer: a decision model analysis. British Journal of Cancer. 106(6), 1045-1052. [Abstract]
  • Staub, L., Dyer, S., Lord, S., Simes, R. (2012), Linking the evidence: intermediate outcomes in medical test assessments. International Journal of Technology Assessment in Health Care. 28(1), 52-58. [Abstract]
  • Staub, L., Lord, S., Simes, R., Dyer, S., Houssami, N., Chen, R., Irwig, L. (2012), Using patient management as a surrogate for patient health outcomes in diagnostic test evaluation. BMC Medical Research Methodology. 12, 12. [Abstract]


  • Lee, C., Simes, R., Brown, C., Lord, S., Wagner, U., Plante, M., Vergote, I., Pisano, C., Parma, G., Burges, A., Bourgeois, H., Högberg, T., Bentley, J., Angleitner-Boubenizek, L., Ferrero, A., Richter, B., Hirte, H., Gebski, V., Pfisterer, J., Pujade-Lauraine, E., Friedlander, M. (2011), Prognostic nomogram to predict progression-free survival in patients with platinum-sensitive recurrent ovarian cancer. British journal of cancer. 105(8), 1144-50. [Abstract]
  • Lee, C., Friedlander, M., Brown, C., Gebski, V., Georgoulopoulos, A., Vergote, I., Pignata, S., Donadello, N., Schmalfeldt, B., Delva, R., Mirza, M., Sauthier, P., Pujade-Lauraine, E., Lord, S., Simes, R. (2011), Early Decline in Cancer Antigen 125 as a Surrogate for Progression-Free Survival in Recurrent Ovarian Cancer. Journal of the National Cancer Institute. 103(17), 1338-42. [Abstract]
  • Lee, C., Hudson, M., Stockler, M., Coates, A., Ackland, S., Gebski, V., Lord, S., Friedlander, M., Boyle, F., Simes, R. (2011), A nomogram to predict survival time in women starting first-line chemotherapy for advanced breast cancer. Breast cancer research and treatment. 129(2), 467-76. [Abstract]
  • Lee, C., Gurney, H., Brown, C., Sorio, R., Donadello, N., Tulunay, G., Meier, W., Bacon, M., Maenpaa, J., Petru, E., Reed, N., Gebski, V., Pujade-Lauraine, E., Lord, S., Simes, R., Friedlander, M. (2011), Carboplatin-paclitaxel-induced leukopenia and neuropathy predict progression-free survival in recurrent ovarian cancer. British journal of cancer. 105(3), 360-5. [Abstract]
  • Staub, L., Barz, T., Melloh, M., Lord, S., Chatfield, M., Bossuyt, P. (2011), Clinical validation study to measure the performance of the Nerve Root Sedimentation Sign for the diagnosis of lumbar spinal stenosis. Contemporary Clinical Trials. 32(3), 470-474. [Abstract]
  • Lord, S., Staub, L., Bossuyt, P., Irwig, L. (2011), Target practice: choosing target conditions for test accuracy studies that are relevant to clinical practice. BMJ. 343, d4684. [Abstract]


  • Barz, T., Staub, L., Melloh, M., Lord, S. (2010), Letters. Spine. 35(24), E1360. [Abstract]
  • Botelho, N., Schneiders, F., Lord, S., Freeman, A., Tyagi, S., Nancarrow, D., Hayward, N., Whiteman, D., Lord, R. (2010), Gene expression alterations in formalin-fixed, paraffin-embedded Barrett's esophagus and esophageal adenocarcinoma tissues. Cancer biology & therapy. 10(2), 172-9. [Abstract]
  • Lee, C., Stockler, M., Coates, A., Gebski, V., Lord, S., Simes, R. (2010), Self-reported health-related quality of life is an independent predictor of chemotherapy treatment benefit and toxicity in women with advanced breast cancer. British journal of cancer. 102(9), 1341-7. [Abstract]
  • Barz, T., Melloh, M., Staub, L., Lord, S., Lange, J., Röder, C., Theis, J., Merk, H. (2010), Nerve Root Sedimentation Sign: Evaluation of a New Radiological Sign in Lumbar Spinal Stenosis. Spine. 35(8), 892-7. [Abstract]
  • Griffiths, A., Dyer, S., Lord, S., Pardy, C., Fraser, I., Eckermann, S. (2010), A cost-effectiveness analysis of in-vitro fertilization by maternal age and number of treatment attempts. Human Reproduction. 25(4), 924-931. [Abstract]
  • Lee, C., Lord, S., Stockler, M., Coates, A., Gebski, V., Simes, R. (2010), Historical cross-trial comparisons for competing treatments in advanced breast cancer - An empirical analysis of bias. European journal of cancer (Oxford, England : 1990). 46(3), 541-8. [Abstract]
  • Creighton, P., Lew, J., Clements, M., Smith, M., Howard, K., Dyer, S., Lord, S., Canfell, K. (2010), Cervical cancer screening in Australia: modelled evaluation of the impact of changing the recommended interval from two to three years. BMC public health. 10(1), 734. [Abstract]


  • Brennan, M., Houssami, N., Lord, S., Macaskill, P., Irwig, L., Dixon, J., Warren, R., Ciatto, S. (2009), Magnetic Resonance Imaging Screening of the Contralateral Breast in Women With Newly Diagnosed Breast Cancer: Systematic Review and Meta-Analysis of Incremental Cancer Detection and Impact on Surgical Management. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 27(33), 5640-9. [Abstract]
  • Lee, C., Lord, S., Coates, A., Simes, R. (2009), Molecular biomarkers to individualise treatment: assessing the evidence. The Medical Journal of Australia. 190(11), 631-636. [Abstract]
  • Houssami, N., Lord, S., Ciatto, S. (2009), Breast cancer screening: emerging role of new imaging techniques as adjuncts to mammography. The Medical Journal of Australia. 190(9), 493-497. [Abstract]
  • Lord, S., Irwig, L., Bossuyt, P. (2009), Using the principles of randomized controlled trial design to guide test evaluation. Medical Decision Making. 29(5), E1-E12. [Abstract]
  • Urwyler, N., Staub, L., Beran, D., Deplazes, M., Lord, S., Alberio, L., Theiler, L., Greif, R. (2009), Is perioperative point-of-care prothrombin time testing accurate compared to the standard laboratory test?. Thrombosis and Haemostasis. 102(4), 779-786. [Abstract]